PH18651A - A pharmaceutical composition containing 3-methyl-1-2-(2-naphthyloxy)-ethyl -2-pyrazolin-5-one and method for treating tumor cell metastasts and growth - Google Patents
A pharmaceutical composition containing 3-methyl-1-2-(2-naphthyloxy)-ethyl -2-pyrazolin-5-one and method for treating tumor cell metastasts and growthInfo
- Publication number
- PH18651A PH18651A PH27109A PH27109A PH18651A PH 18651 A PH18651 A PH 18651A PH 27109 A PH27109 A PH 27109A PH 27109 A PH27109 A PH 27109A PH 18651 A PH18651 A PH 18651A
- Authority
- PH
- Philippines
- Prior art keywords
- metastasts
- pyrazolin
- naphthyloxy
- ethyl
- growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25186481A | 1981-04-07 | 1981-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH18651A true PH18651A (en) | 1985-08-23 |
Family
ID=22953719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH27109A PH18651A (en) | 1981-04-07 | 1982-04-06 | A pharmaceutical composition containing 3-methyl-1-2-(2-naphthyloxy)-ethyl -2-pyrazolin-5-one and method for treating tumor cell metastasts and growth |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0062319A1 (xx) |
JP (1) | JPS57179163A (xx) |
AU (1) | AU551063B2 (xx) |
BE (1) | BE892772A (xx) |
CA (1) | CA1265451A (xx) |
CH (1) | CH651753A5 (xx) |
DE (1) | DE3212068A1 (xx) |
ES (3) | ES8307753A1 (xx) |
FR (1) | FR2502954B1 (xx) |
GB (1) | GB2095997B (xx) |
GR (1) | GR75460B (xx) |
IL (1) | IL65423A (xx) |
IT (1) | IT1150790B (xx) |
NL (1) | NL8201321A (xx) |
NZ (1) | NZ200234A (xx) |
PH (1) | PH18651A (xx) |
ZA (1) | ZA822335B (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040180891A1 (en) * | 2001-09-25 | 2004-09-16 | Uday Khire | Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2427272C3 (de) * | 1974-06-06 | 1981-10-01 | Bayer Ag, 5090 Leverkusen | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum |
-
1982
- 1982-03-30 NL NL8201321A patent/NL8201321A/nl not_active Application Discontinuation
- 1982-03-31 CA CA000400261A patent/CA1265451A/en not_active Expired - Lifetime
- 1982-04-01 DE DE19823212068 patent/DE3212068A1/de not_active Withdrawn
- 1982-04-02 EP EP82102800A patent/EP0062319A1/de not_active Withdrawn
- 1982-04-02 GB GB8209782A patent/GB2095997B/en not_active Expired
- 1982-04-05 ZA ZA822335A patent/ZA822335B/xx unknown
- 1982-04-05 AU AU82353/82A patent/AU551063B2/en not_active Ceased
- 1982-04-05 GR GR67819A patent/GR75460B/el unknown
- 1982-04-05 CH CH2133/82A patent/CH651753A5/de not_active IP Right Cessation
- 1982-04-05 IL IL65423A patent/IL65423A/xx unknown
- 1982-04-05 JP JP57055557A patent/JPS57179163A/ja active Pending
- 1982-04-05 NZ NZ200234A patent/NZ200234A/en unknown
- 1982-04-06 FR FR8205947A patent/FR2502954B1/fr not_active Expired
- 1982-04-06 BE BE0/207764A patent/BE892772A/fr not_active IP Right Cessation
- 1982-04-06 ES ES511209A patent/ES8307753A1/es not_active Expired
- 1982-04-06 PH PH27109A patent/PH18651A/en unknown
- 1982-04-06 IT IT20621/82A patent/IT1150790B/it active
-
1983
- 1983-04-14 ES ES521457A patent/ES8404995A1/es not_active Expired
- 1983-04-14 ES ES521456A patent/ES521456A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
GB2095997B (en) | 1986-01-22 |
ZA822335B (en) | 1983-03-30 |
ES521457A0 (es) | 1984-05-16 |
IT8220621A0 (it) | 1982-04-06 |
IL65423A (en) | 1984-12-31 |
FR2502954A1 (fr) | 1982-10-08 |
ES8404995A1 (es) | 1984-05-16 |
GB2095997A (en) | 1982-10-13 |
FR2502954B1 (fr) | 1985-10-25 |
DE3212068A1 (de) | 1982-11-18 |
ES8404994A1 (es) | 1984-05-16 |
NZ200234A (en) | 1985-07-12 |
AU8235382A (en) | 1982-10-14 |
BE892772A (fr) | 1982-10-06 |
CA1265451A (en) | 1990-02-06 |
IL65423A0 (en) | 1982-07-30 |
GR75460B (xx) | 1984-07-20 |
AU551063B2 (en) | 1986-04-17 |
CH651753A5 (de) | 1985-10-15 |
ES511209A0 (es) | 1983-08-01 |
ES521456A0 (es) | 1984-05-16 |
NL8201321A (nl) | 1982-11-01 |
JPS57179163A (en) | 1982-11-04 |
IT8220621A1 (it) | 1983-10-06 |
ES8307753A1 (es) | 1983-08-01 |
IT1150790B (it) | 1986-12-17 |
EP0062319A1 (de) | 1982-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3377462D1 (en) | Improved material and method for dentistry | |
EP0101285A3 (en) | A substratum for cell culture and a method using it | |
GB2162065B (en) | Implant and method for production thereof | |
GB2114573B (en) | Stabilized insulin solutions and methods for their production | |
BG36073A1 (en) | Method for introducing biologically active substances in plants | |
EG16473A (en) | Process for preparing n-formyl and n-hydroxy-methyl-3-phenoxy-1-azetidinecarboxamides | |
ZA863613B (en) | Method and apparatus for dividing plant material | |
EP0185646A3 (en) | Process for handling artificial turf | |
DE3373188D1 (en) | Process for preparing cell and tissue regenerating substances | |
GB2093348B (en) | Pharmaceutical composition for implantation | |
DE3373113D1 (en) | Process and apparatus for cultivating tissue cells | |
GR862411B (en) | Arylmethylazoles their salts method for preparing them means containing them and their application | |
DE3568798D1 (en) | Cell and tissue culture process and apparatus | |
HUT37932A (en) | Process for preparing 4-hydroxy-2h-1-benzo-thiopyrane-2-one-derivatives and for preparing rhodenticide preparations comprising such compounds | |
GB2166732B (en) | Process for preparing l-carnitine and salts thereof | |
GB2167034B (en) | Capsules and process for their preparation | |
PH18651A (en) | A pharmaceutical composition containing 3-methyl-1-2-(2-naphthyloxy)-ethyl -2-pyrazolin-5-one and method for treating tumor cell metastasts and growth | |
HUT42293A (en) | Microbiocidal composition and process for treating plants | |
EP0182173A3 (en) | Monocyclic bis-oxethylsulfonyl-anilines and process for their preparation | |
DE3360934D1 (en) | Diaryliodosyl salts and process for their preparation | |
GB8529946D0 (en) | Method and apparatus for growing cdxhg1-xte | |
GB8816436D0 (en) | Substances for inhibiting cell growth | |
DE3562089D1 (en) | Monocyclic bis-oxyethylsulfonyl-benzenes and process for their preparation | |
JPS573634A (en) | Implant material for live body and method | |
DE3563053D1 (en) | Bis-phosphonium salts and process for their preparation |